5-HT neuroendocrine function in major depression: Prolactin and cortisol responses to D-fenfluramine

Psychological Medicine

Volumn 26, Issue 6, 1996, Pages 1191-1196

  Park, S B G ^a   Williamson, D J ^a   Cowen, P J ^a  

^a Littlemore Mental Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; HYDROCORTISONE; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; MELANCHOLIA; ORAL DRUG ADMINISTRATION; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION;

EID: 0029820723     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291700035911     Document Type: Article

References (31)

1. Anderson, I. M., Ware, C. J., da Roza Davis, J. M. & Cowen, P. J. (1992). Decreased 5-HT-mediated prolactin release in major depression. British Journal of Psychiatry 160, 372-378.
2. Asnis, G. M., Eisenberg, J., van Praag, H. M., Lemus, C. Z., Friedman, H. & Miller, A. H. (1988). The neuroendocrine response to fenfluramine in depressives and normal controls. Biological Psychiatry 24, 117-120.
3. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. E. & Erbaugh, J. E. (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561-567.
4. Blier, P. & de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 15, 220-226.
5. 2 receptors. Human Psychopharmacology 1, 93-97.
6. Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., Cooper, T. B., Mohs, R. C. & Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry 46, 587-599.
7. Cowen, P. J. (1993). Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clinical Neuropharmacology 16 (Suppl. 3), S6-S18.
8. Cowen, P. J. & Charig, E. M. (1987). Neuroendocrine responses to intravenous tryptophan in major depression. Archives of General Psychiatry 44, 958-966.
9. Deakin, J. F. W. & Graeff, F. G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology 5, 305-315.
10. Delgado, P. L., Price. L. H., Heninger, G. R. & Charney, D. S. (1992). Neurochemistry. In Handbook of Affective Disorders (ed. E. S. Paykel), pp. 219-253. Churchill Livingstone: Edinburgh.
11. 1A receptors and antidepressant drug action. In Psychopharmacology of Depression (ed S. A. Montgomery and T. H. Corn), pp. 66-86. Oxford University Press: Oxford.
12. Golden R. N., Hsiao, J. K., Lane, E., Ekstrom, D., Rogers, S., Hicks, R. & Potter, W. Z. (1990). Abnormal neuroendocrine responsivity to clomipramine challenge in depressed patients. Psychiatry Research 31, 39-47.
13. Goodall, E. M., Cowen, P. J., Franklin, M. & Silverstone, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacology 112, 461-466.
14. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
15. Lichtenberg, P., Shapira, B., Gillon, D., Kindler, S., Cooper, T. B., Newman, M. E. & Lerer, B. (1992). Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatric Research 43, 137-146.
16. Lopez-Ibor, J. J., Saiz-Ruiz, J. & Moral-Iglesais, L. (1989). Neuroendocrine challenges in the diagnosis of depressive disorders. British Journal of Psychiatry 154 (Suppl 4), 73-76.
17. Macs, M., Jacobs, M.-P., Suy, E., Minner, B. & Raus, J. (1989). Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major depressed patients. Neuropsychobiology 21, 192-196.
18. Macs, M., D'Hondt, P., Suy, E., Minner, B., Vandervorst, C. & Raus, J. (1991). HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Progress in Neuropsychopharmacology and Biological Psychiatry 15, 781-790.
19. Mitchell, P. & Smythe, G. (1990). Hormonal responses to fenfluramine in depressed and control subjects. Journal of Affective Disorders 19, 43-51.
20. O'Keane, V. & Dinan, T. G. (1991). Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry 148, 1009-1015.
21. Park, S. B. G. & Cowen, P. J. (1995). Effect of pindolol on the prolactin response to D-fenfluramine. Psychopyharmacology 118, 471-474.
22. Power, A. C. & Cowen, P. J. (1992). Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression Molecular Aspects of Medicine 13, 205-220.
23. Richards, R. P., Gordon, B. H., Ings, R. M., Campbell, D. B. & King, L. J. (1989). The measurement of D-fenfluramine and its metabolite. D-norfenfluramine, in plasma and urine with an application of the method to pharmacokinetic studies. Xenobiotica 19, 547-553.
24. Siever, L. J., Murphy, D. L., Slater, S., de la Vega, E. & Lipper, S. (1984). Plasma prolactin changes following fenfluramine in depressed patients compared to controls : an evaluation of central serotonergic responsivity in depression. Life Sciences 34, 1029-1039.
25. Smith, C. E., Ware. C. J. & Cowen, P. J. (1991). Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology 103, 140-142.
26. Targum, S. D. (1990). Differential responses to anxiolgenic challenge studies in patients with major depressive disorder and panic disorder. Biological Psychiatry 28, 21-34.
27. Thompson, P. A., Maes, M. & Meltzer, H. Y. (1994). Effect of the placebo control condition in neuroendocrine challenge studies. Psychiatry Research 52, 317-326.
28. Van de Kar, L. (1991). Neuroendocrine pharmacology of serotonergic (5-HT) neurones. Annual Review of Pharmacology and Toxicology 31, 289-320.
29. Van de Kar, L. D., Urban, J. H., Richardson, K. D. & Belhea, C. L. (1985). Pharmacological studies on the serotonergic and nonserotonin-mediated stimulation of prolactin and corticosteroid secretion by fenfluramine. Neuroendocrinology 41, 283-288.
30. Walsh, A. E. S., Oldman, A. D., Franklin, M., Fairburn, C. G. & Cowen, P. J. (1995). Dieting decreases plasma tryptophan and increases the prolactin response to D-fenfluramine in women but not men. Journal of Affective Disorders 33, 89-97.
31. Weizman, A. M., Gil-Ad, I., Tyano, S. & Laron, Z. (1988). Plasma cortisol, prolactin, growth hormone, and immunoreactive betaendorphin response to fenfluramine challenge in depressed patients. Clinical Neuropharmacology 11, 250-256.